{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:03:08Z","timestamp":1793041388057,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.neuropharm.2024.110239","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T23:07:37Z","timestamp":1732662457000},"page":"110239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["CCR1 antagonist as a potential modulator of inflammatory, autophagic, and apoptotic markers in spinal cord injury"],"prefix":"10.1016","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3771-6910","authenticated-orcid":false,"given":"Ahmed","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7224-8158","authenticated-orcid":false,"given":"Alberto","family":"Repici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Paola","family":"Capra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Mannino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Catalfamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Campolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Paterniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Ardizzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110239_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105069","article-title":"Targeting apoptosis and autophagy following spinal cord injury: therapeutic approaches to polyphenols and candidate phytochemicals","volume":"160","author":"Abbaszadeh","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2024.110239_bib2","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/BOT.0000000000000943","article-title":"Spinal cord injury\u2014what are the controversies?","volume":"31","author":"Ahuja","year":"2017","journal-title":"J. Orthop. Trauma"},{"key":"10.1016\/j.neuropharm.2024.110239_bib3","first-page":"1","article-title":"Traumatic spinal cord injury","volume":"3","author":"Ahuja","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.neuropharm.2024.110239_bib4","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/01.ASN.0000130082.67775.60","article-title":"Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas (lpr) mice","volume":"15","author":"Anders","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.neuropharm.2024.110239_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12974-022-02457-3","article-title":"SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration","volume":"19","author":"Ardizzone","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2024.110239_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914654","article-title":"bFGF-like activity supported tissue regeneration, modulated neuroinflammation, and rebalanced Ca2+ homeostasis following spinal cord injury","volume":"24","author":"Ardizzone","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110239_bib7","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.3390\/ijms22041967","article-title":"Effect of ultra-micronized-palmitoylethanolamide and acetyl-l-carnitine on experimental model of inflammatory pain","volume":"22","author":"Ardizzone","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110239_bib8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sc.2015.28","article-title":"A pilot study on temporal changes in IL-1\u03b2 and TNF-\u03b1 serum levels after spinal cord injury: the serum level of TNF-\u03b1 in acute SCI patients as a possible marker for neurological remission","volume":"53","author":"Biglari","year":"2015","journal-title":"Spinal Cord"},{"key":"10.1016\/j.neuropharm.2024.110239_bib9","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.3390\/ijms22083927","article-title":"PEA-OXA mitigates oxaliplatin-induced painful neuropathy through NF-\u03baB\/Nrf-2 Axis","volume":"22","author":"Campolo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110239_bib10","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1007\/s12035-020-02033-x","article-title":"Role of ABT888, a novel poly (ADP-ribose) polymerase (PARP) inhibitor in countering autophagy and apoptotic processes associated to spinal cord injury","volume":"57","author":"Casili","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110239_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.freeradbiomed.2017.10.001","article-title":"Dysfunction of autophagy and endosomal-lysosomal pathways: roles in pathogenesis of Down syndrome and Alzheimer's Disease","volume":"114","author":"Colacurcio","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2024.110239_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.6061\/clinics\/2012(10)16","article-title":"Therapeutic approaches for spinal cord injury","volume":"67","author":"Cristante","year":"2012","journal-title":"Clinics"},{"key":"10.1016\/j.neuropharm.2024.110239_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/JIR.S254717","article-title":"Therapeutic effect of CC chemokine receptor type 1 (CCR1) antagonist BX471 on allergic Rhinitis","author":"Feng","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.neuropharm.2024.110239_bib14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.yjmcc.2006.03.432","article-title":"A CCR1 antagonist prevents the development of experimental autoimmune myocarditis in association with T cell inactivation","volume":"40","author":"Futamatsu","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.neuropharm.2024.110239_bib15","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1002\/mco2.311","article-title":"Modulation of the immunity and inflammation by autophagy","volume":"4","author":"Gan","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.neuropharm.2024.110239_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135305","article-title":"Wnt-3a improves functional recovery through autophagy activation via inhibiting the mTOR signaling pathway after spinal cord injury","volume":"737","author":"Gao","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2024.110239_bib17","series-title":"Pharmacological and Nonpharmacological Therapeutic Strategies Based on the Pathophysiology of Acute and Chronic Spinal Cord Injury","first-page":"23","author":"Garcia","year":"2018"},{"key":"10.1016\/j.neuropharm.2024.110239_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41420-021-00455-7","article-title":"Lysine-specific demethylase 1 inhibition enhances autophagy and attenuates early-stage post-spinal cord injury apoptosis","volume":"7","author":"Gu","year":"2021","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.neuropharm.2024.110239_bib19","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.1073\/pnas.1611282113","article-title":"Autophagy induction stabilizes microtubules and promotes axon regeneration after spinal cord injury","volume":"113","author":"He","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2024.110239_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/mpa.0b013e31802e7598","article-title":"Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modulating neutrophil recruitment","volume":"34","author":"He","year":"2007","journal-title":"Pancreas"},{"key":"10.1016\/j.neuropharm.2024.110239_bib21","doi-asserted-by":"crossref","first-page":"G1173","DOI":"10.1152\/ajpgi.00420.2006","article-title":"Treatment with BX471, a CC chemokine receptor 1 antagonist, attenuates systemic inflammatory response during sepsis","volume":"292","author":"He","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.neuropharm.2024.110239_bib22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2174\/1389557054867057","article-title":"BX471: a CCR1 antagonist with anti-inflammatory activity in man","volume":"5","author":"Horuk","year":"2005","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.neuropharm.2024.110239_bib23","first-page":"369","article-title":"Acute spinal cord injury in rats induces autophagy activation","volume":"24","author":"Hou","year":"2014","journal-title":"Turkish Neurosurgery"},{"key":"10.1016\/j.neuropharm.2024.110239_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fncel.2019.00171","article-title":"Mast cells in neurodegenerative disease","volume":"13","author":"Jones","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110239_bib25","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1523\/JNEUROSCI.0305-05.2005","article-title":"Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury","volume":"25","author":"Jones","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110239_bib26","first-page":"3","article-title":"Epidemiology of worldwide spinal cord injury: a literature review","volume":"6","author":"Kang","year":"2018","journal-title":"J. Neurorestoratol."},{"key":"10.1016\/j.neuropharm.2024.110239_bib27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4161\/auto.5.3.7724","article-title":"The role of autophagy in spinal cord injury","volume":"5","author":"Kanno","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2024.110239_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4161\/auto.1.1.1536","article-title":"Autophagy and p70S6 kinase","volume":"1","author":"Klionsky","year":"2005","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2024.110239_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3171\/2010.12.SPINE10480","article-title":"Spatiotemporal CCR1, CCL3 (MIP-1\u03b1), CXCR4, CXCL12 (SDF-1\u03b1) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain","volume":"14","author":"Knerlich-Lukoschus","year":"2011","journal-title":"J. Neurosurg. Spine"},{"key":"10.1016\/j.neuropharm.2024.110239_bib30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/neu.2009.1080","article-title":"Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury","volume":"27","author":"Kwon","year":"2010","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neuropharm.2024.110239_bib31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3390\/antiox9100945","article-title":"Properties of a new food supplement containing Actinia equina extract","volume":"9","author":"Lanza","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.neuropharm.2024.110239_bib32","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s12264-019-00368-7","article-title":"Pros and cons: autophagy in acute spinal cord injury","volume":"35","author":"Li","year":"2019","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuropharm.2024.110239_bib33","doi-asserted-by":"crossref","first-page":"19000","DOI":"10.1074\/jbc.M001222200","article-title":"Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1","volume":"275","author":"Liang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2024.110239_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.761273","article-title":"Biological functions and therapeutic potential of autophagy in spinal cord injury","volume":"9","author":"Liao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2024.110239_bib35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/ars.2015.6306","article-title":"Function and mechanisms of autophagy in brain and spinal cord trauma","volume":"23","author":"Lipinski","year":"2015","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.neuropharm.2024.110239_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.527","article-title":"Disrupted autophagy after spinal cord injury is associated with ER stress and neuronal cell death","volume":"6","author":"Liu","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2024.110239_bib37","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/biology11060939","article-title":"The inflammatory response after moderate contusion spinal cord injury: a time study","volume":"11","author":"Lund","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.neuropharm.2024.110239_bib38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/1673-5374.317982","article-title":"Rapid GFAP and Iba1 expression changes in the female rat brain following spinal cord injury","volume":"17","author":"Mandwie","year":"2022","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/j.neuropharm.2024.110239_bib39","first-page":"214","article-title":"Bcl-2: Beclin 1 complex: multiple, mechanisms regulating autophagy\/apoptosis toggle switch","volume":"2","author":"Marquez","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.neuropharm.2024.110239_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","article-title":"Autophagy in Huntington disease and huntingtin in autophagy","volume":"38","author":"Martin","year":"2015","journal-title":"Trends in neurosciences"},{"key":"10.1016\/j.neuropharm.2024.110239_bib41","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P","article-title":"Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury","volume":"58","author":"McGavern","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2024.110239_bib42","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","article-title":"Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities","volume":"93","author":"Menzies","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110239_bib43","first-page":"302","article-title":"Improving your care of patients with spinal cord injury\/disease","volume":"65","author":"Mishori","year":"2016","journal-title":"J. Fam. Pract."},{"key":"10.1016\/j.neuropharm.2024.110239_bib44","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s13311-018-0631-6","article-title":"Spinal cord injury scarring and inflammation: therapies targeting glial and inflammatory responses","volume":"15","author":"Orr","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2024.110239_bib45","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.3390\/ijms25084337","article-title":"Novel findings on CCR1 receptor in CNS disorders: a pathogenic marker useful in controlling neuroimmune and neuroinflammatory mechanisms in Parkinson's disease","volume":"25","author":"Repici","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110239_bib46","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s41418-021-00907-8","article-title":"USP11 regulates autophagy-dependent ferroptosis after spinal cord ischemia-reperfusion injury by deubiquitinating Beclin 1","volume":"29","author":"Rong","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2024.110239_bib47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41419-019-1571-8","article-title":"Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy","volume":"10","author":"Rong","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2024.110239_bib48","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9647","article-title":"Prognostic value of the autophagy markers LC3 and p62\/SQSTM1 in early-stage non-small cell lung cancer","volume":"7","author":"Schl\u00e4fli","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuropharm.2024.110239_bib49","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3390\/ijms23042269","article-title":"Efficacy of a product containing xyloglucan and pea protein on intestinal barrier function in a partial restraint stress animal model","volume":"23","author":"Scuderi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110239_bib50","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.biopha.2017.04.126","article-title":"Pathophysiology, mechanisms and applications of mesenchymal stem cells for the treatment of spinal cord injury","volume":"91","author":"Shende","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2024.110239_bib51","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/imm.12170","article-title":"Mast cells, glia and neuroinflammation: partners in crime?","volume":"141","author":"Skaper","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.neuropharm.2024.110239_bib52","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4161\/auto.7.12.17892","article-title":"Accumulation of p62 in degenerated spinal cord under chronic mechanical compression: functional analysis of p62 and autophagy in hypoxic neuronal cells","volume":"7","author":"Tanabe","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2024.110239_bib53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000540460","article-title":"Inflammatory role of CCR1 in the central nervous system","volume":"31","author":"Tian","year":"2024","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neuropharm.2024.110239_bib54","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2125.2009.03460.x","article-title":"Assessment of QTc\u2010prolonging potential of BX471 in healthy volunteers. A \u2018thorough QTc study\u2019following ICH E14 using various QT correction methods","volume":"68","author":"Vandemeulebroecke","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110239_bib55","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/j.1523-1755.2004.66038.x","article-title":"CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome","volume":"66","author":"Vielhauer","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.neuropharm.2024.110239_bib56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000357382","article-title":"Neuroprotective effects of autophagy induced by rapamycin in rat acute spinal cord injury model","volume":"21","author":"Wang","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neuropharm.2024.110239_bib57","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.7150\/ijbs.57825","article-title":"Betulinic acid inhibits pyroptosis in spinal cord injury by augmenting autophagy via the AMPK-mTOR-TFEB signaling pathway","volume":"17","author":"Wu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110239_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/cells9010070","article-title":"Autophagy and macrophage functions: inflammatory response and phagocytosis","volume":"9","author":"Wu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2024.110239_bib59","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s13311-019-00821-5","article-title":"CCR1 activation promotes neuroinflammation through CCR1\/TPR1\/ERK1\/2 signaling pathway after intracerebral hemorrhage in mice","volume":"17","author":"Yan","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2024.110239_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-018-0422-3","article-title":"Pathological changes of distal motor neurons after complete spinal cord injury","volume":"12","author":"Yokota","year":"2019","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2024.110239_bib61","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4161\/auto.27710","article-title":"MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Zhang","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2024.110239_bib62","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.4161\/auto.25132","article-title":"Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance","volume":"9","author":"Zhang","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2024.110239_bib63","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2017.02.027","article-title":"Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1\/AMPK signaling pathway","volume":"348","author":"Zhao","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110239_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8898996","article-title":"Trehalose augments neuron survival and improves recovery from spinal cord injury via mTOR\u2010independent activation of autophagy","volume":"2021","author":"Zhou","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2024.110239_bib65","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/ijms18020466","article-title":"The temporal pattern, flux, and function of autophagy in spinal cord injury","volume":"18","author":"Zhou","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110239_bib66","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1212\/01.wnl.0000244420.68037.86","article-title":"Blockade of chemokine signaling in patients with multiple sclerosis","volume":"67","author":"Zipp","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2024.110239_bib67","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s43440-023-00486-0","article-title":"Therapeutic potential of autophagy in immunity and inflammation: current and future perspectives","volume":"75","author":"Zuo","year":"2023","journal-title":"Pharmacol. Rep."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824004088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824004088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T21:00:25Z","timestamp":1733691625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824004088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":67,"alternative-id":["S0028390824004088"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110239","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CCR1 antagonist as a potential modulator of inflammatory, autophagic, and apoptotic markers in spinal cord injury","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110239"}}